An IHC analysis showed that CD32B (the receptor of FGL2) exhibited the highest levels of expression in ectopic lesions (ovarian endometriosis), lower expression levels in eutopic endometrium, and the lowest expression levels in the normal endometrium (Fig. 1c). This evidence concerns the gene FCGR2B and ovarian endometriosis.